Net Deals Web Search

Search results

1. Results From The WOW.Com Content Network

2. Lars Fruergaard Jørgensen - Wikipedia

   en.wikipedia.org/wiki/Lars_Fruergaard_Jørgensen

   Employer. Novo Nordisk (since 1994) Lars Fruergaard Jørgensen (born 29 November 1966) [ 1] is a Danish businessman, the Chief Executive of Novo Nordisk since January 2017 and Chairman of the European Federation of Pharmaceutical Industries and Associations . He was named as the Financial Times Person of the Year in December 2023.

3. Lars Rebien Sørensen - Wikipedia

   en.wikipedia.org/wiki/Lars_Rebien_Sørensen

   October 10, 1954 (age 69) Education. The Royal Veterinary and Agricultural University, University of Copenhagen. Occupation (s) Former CEO at Novo Nordisk, chair of Novo Nordisk Foundation (2020. Employer. Novo Nordisk (until 2016) Lars Rebien Sørensen (born 10 October 1954) [1] is a Danish businessman and former CEO of the pharmaceutical ...

4. Novo Nordisk - Wikipedia

   en.wikipedia.org/wiki/Novo_Nordisk

   Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd [ 3] with production facilities in nine countries and affiliates or offices in five countries. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28% of its shares and a majority (77%) of its voting shares.

5. Novo Nordisk plans record expansion in NC, promising 1,000 ...

   www.aol.com/novo-nordisk-plans-record-expansion...

   In 2023, the latter generated around $4.5 billion in sales, and Novo Nordisk this spring said approximately 25,000 new people in the U.S. start taking Wegovy each week.

6. Novo Nordisk's unique structure gives it an extra edge — and ...

   www.aol.com/finance/novo-nordisks-unique...

   The Novo Nordisk Foundation didn't return Yahoo Finance's request to be interviewed for this story. Allie Garfinkle is a Senior Tech Reporter at Yahoo Finance. Follow her on X, formerly Twitter ...

7. Novo Nordisk to build $220 million raw materials plant ... - AOL

   www.aol.com/novo-nordisk-pharmatech-unit-build...

   August 16, 2024 at 1:31 AM. OSLO (Reuters) -Novo Nordisk's Pharmatech unit will build a 1.5 billion Danish crowns ($220.83 million) plant in Denmark to meet significantly higher demand for the ...

8. Lotte Bjerre Knudsen - Wikipedia

   en.wikipedia.org/wiki/Lotte_Bjerre_Knudsen

   Lotte Bjerre Knudsen. Lotte Bjerre Knudsen (born March 10, 1964) is a Danish scientist and university professor. She led the development of liraglutide and semaglutide, [third-party source needed] two notable drugs approved for indications in the treatment of diabetes and obesity. [ 1] [third-party source needed]

9. Novo Nordisk's Growth Opportunities Go Far Beyond Just ... - AOL

   www.aol.com/novo-nordisks-growth-opportunities...

   Novo Nordisk (NYSE: NVO) is a big name in diabetes care and weight loss. And that's the primary reason people invest in the business today: the lucrative opportunities it has in those areas of ...